Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients

NCT06366217 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06366217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06366217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2024
Completion date
July 7, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dilation, pupil reaction absent